chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Heart rate, Heart rate increased, Oxygen saturation, Oxygen saturation decreased
Clinical narrative: my heart rate was 96-110; Pulse Ox Saturation Rate (SP02) rate of 88-93; extreme headache; This is a spontaneous report from a contactable consumer (patient). A 61-years-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: ER8729), via an unspecified route on 11Apr2021 at 22:30 (at the age of 61-years) as dose number unknown, single in the left arm for covid-19 immunisation. The patient medical history included Diabetes II, Hypothyroidism, Hypertension, Hyperlipidaemia, NAFLD. The patient concomitant medications included olmesartan medoxomil (BENICAR), Levothyroxin, Hydrochlorothiazide (HCTZ), Metformin, nifedipine (PROCARDIA) from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021, the patient experienced extreme headache and had Pulse Ox Saturation Rate (SP02) rate of 88-93, her heart rate was 96-110. The events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was resolved with sequel.  No follow-up attempts are possible. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Headache, Lymphadenopathy, Palpitations
Clinical narrative: slight headache; light headed; heart raced; throat felt a bit constricted; diarrhea; a ringing in my left ear; My Tinnitus seems to have increased as well in both ears; Lymph nodes under arms are so big they are cutting off circulation to my arms. As big as baseballs; This is a spontaneous report from a contactable consumer (patient) or other non HCP.  A 62-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch no./Lot number and Expiration date was not reported), via an unspecified route of administration in Arm Left on 18Apr2021 at 15:00 (at the age of 62-years-old) as dose 1, single for COVID-19 immunisation. The patient's medical history included Chronic lymphocytic leukaemia, Known allergies: Pneumonia vaccine all from unknown date unknown if ongoing. The patient concomitant medications included Atorvastatin, fenofibrate, carvedilol, losartan all taken for unspecified indication start and stop date were not reported. patient did not received any other vaccine within four week prior to the vaccination. patient did not diagnosis covid prior and post to the vaccination. On 18Apr2021, at 15:15, 15 min after first dose, patient experienced light headed, heart raced, throat felt a bit constricted. on 18Apr2021, patient experienced a ringing in his left ear, diarrhea, his Tinnitus seems to have increased as well in both ears, Lymph nodes under arms are so big they are cutting off circulation to my arms. As big as baseballs. on 18Apr2021, 1 hr 15 min after first dose patient experienced slight headache. Adverse events resulted in Doctor or other healthcare professional office/clinic visit it was reported. patient did not received any treatment for events. it was reported that on 18Apr21 at 3:05 at (specialty pharmacy name) in left upper arm his Arm never got sore at 3:15 he had got light headed heart raced, throat felt a bit constricted, at 4:15 developed slight headache. Continued for 6 days he had diarrhea for 4 days he also have had a ringing in his left ear that was not there. his tinnitis seems to have increased as well in both ears. Lymph nodes under arms are so big they are cutting off circulation to his arms. As big as baseballs. Both arms. The outcome of events a ringing in his left ear was recovered on unspecified date in Apr2021, outcome of event his Tinnitus seems to have increased as well in both ears, Lymph nodes under arms are so big they are cutting off circulation to my arms. As big as baseballs was unknown, outcome of event slight headache recovered on 25Apr2021, outcome of event diarrhea recovered on 22Apr2021, while outcome of other events was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Throat tightness, Tinnitus
Clinical narrative: slight headache; light headed; heart raced; throat felt a bit constricted; diarrhea; a ringing in my left ear; My Tinnitus seems to have increased as well in both ears; Lymph nodes under arms are so big they are cutting off circulation to my arms. As big as baseballs; This is a spontaneous report from a contactable consumer (patient) or other non HCP.  A 62-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch no./Lot number and Expiration date was not reported), via an unspecified route of administration in Arm Left on 18Apr2021 at 15:00 (at the age of 62-years-old) as dose 1, single for COVID-19 immunisation. The patient's medical history included Chronic lymphocytic leukaemia, Known allergies: Pneumonia vaccine all from unknown date unknown if ongoing. The patient concomitant medications included Atorvastatin, fenofibrate, carvedilol, losartan all taken for unspecified indication start and stop date were not reported. patient did not received any other vaccine within four week prior to the vaccination. patient did not diagnosis covid prior and post to the vaccination. On 18Apr2021, at 15:15, 15 min after first dose, patient experienced light headed, heart raced, throat felt a bit constricted. on 18Apr2021, patient experienced a ringing in his left ear, diarrhea, his Tinnitus seems to have increased as well in both ears, Lymph nodes under arms are so big they are cutting off circulation to my arms. As big as baseballs. on 18Apr2021, 1 hr 15 min after first dose patient experienced slight headache. Adverse events resulted in Doctor or other healthcare professional office/clinic visit it was reported. patient did not received any treatment for events. it was reported that on 18Apr21 at 3:05 at (specialty pharmacy name) in left upper arm his Arm never got sore at 3:15 he had got light headed heart raced, throat felt a bit constricted, at 4:15 developed slight headache. Continued for 6 days he had diarrhea for 4 days he also have had a ringing in his left ear that was not there. his tinnitis seems to have increased as well in both ears. Lymph nodes under arms are so big they are cutting off circulation to his arms. As big as baseballs. Both arms. The outcome of events a ringing in his left ear was recovered on unspecified date in Apr2021, outcome of event his Tinnitus seems to have increased as well in both ears, Lymph nodes under arms are so big they are cutting off circulation to my arms. As big as baseballs was unknown, outcome of event slight headache recovered on 25Apr2021, outcome of event diarrhea recovered on 22Apr2021, while outcome of other events was not recovered.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Influenza, Lethargy, Musculoskeletal stiffness, Myalgia
Clinical narrative: Stiffness; Lethargic; Headache; Intense muscular pain in the lower back (left side) laying down flat on back sent shooting pain; Shooting pain/bit sore; Mild flu; Seasonal allergy type feeling; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 11:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fluticasone propionate/salmeterol xinafoate (ADVAIR), clonazepam (MANUFACTURER UNKNOWN), lamotrigine (MANUFACTURER UNKNOWN), naltrexone (MANUFACTURER UNKNOWN) and loratadine (LORAT); all taken on unknown dates for unknown indications and unknown if ongoing. On 17Apr2021 at 23:30, 12 hours post shot, the patient experienced mild flu/seasonal allergy type feeling. On 18Apr2021 at 15:00, the patient experienced stiffness, headache and was lethargic. The symptoms progressed throughout the day, some were lessening, others were worsening. On 18Apr2021, about 36 hours after shot, the patient experienced the worst effect - intense muscular pain in the lower back (left side). The patient laid down flat on back which sent shooting pain. The patient had a high pain tolerance and it was intense and the patient was eventually able to find a comfortable position in bed, fetal on right side with head at odd angle. On 19Apr2021, next day the patient was still sore but the intense shooting pain had passed and was able to sleep. The patient reported that it was still a bit sore/stiff. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events mild flu, seasonal allergy type feeling, headache, and lethargic were recovered on an unknown date in Apr2021. The clinical outcome of the events intense muscular pain in the lower back (left side) laying down flat on back sent shooting pain, shooting pain/bit sore and stiffness were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Seasonal allergy
Clinical narrative: Stiffness; Lethargic; Headache; Intense muscular pain in the lower back (left side) laying down flat on back sent shooting pain; Shooting pain/bit sore; Mild flu; Seasonal allergy type feeling; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 17Apr2021 at 11:30 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and seasonal allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included fluticasone propionate/salmeterol xinafoate (ADVAIR), clonazepam (MANUFACTURER UNKNOWN), lamotrigine (MANUFACTURER UNKNOWN), naltrexone (MANUFACTURER UNKNOWN) and loratadine (LORAT); all taken on unknown dates for unknown indications and unknown if ongoing. On 17Apr2021 at 23:30, 12 hours post shot, the patient experienced mild flu/seasonal allergy type feeling. On 18Apr2021 at 15:00, the patient experienced stiffness, headache and was lethargic. The symptoms progressed throughout the day, some were lessening, others were worsening. On 18Apr2021, about 36 hours after shot, the patient experienced the worst effect - intense muscular pain in the lower back (left side). The patient laid down flat on back which sent shooting pain. The patient had a high pain tolerance and it was intense and the patient was eventually able to find a comfortable position in bed, fetal on right side with head at odd angle. On 19Apr2021, next day the patient was still sore but the intense shooting pain had passed and was able to sleep. The patient reported that it was still a bit sore/stiff. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events mild flu, seasonal allergy type feeling, headache, and lethargic were recovered on an unknown date in Apr2021. The clinical outcome of the events intense muscular pain in the lower back (left side) laying down flat on back sent shooting pain, shooting pain/bit sore and stiffness were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Excessive hair loss began; This is a spontaneous report from a contactable consumer. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Mar2021 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included Human Immunodeficiency Virus (HIV) positive. The patient was allergic to shellfish and Penicillin (PCN). Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 18Mar2021 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown if the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Mar2021, about 1 week after vaccination, the patient experienced excessive hair loss. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event and included treatment with ketoconazole. The clinical outcome of the event excessive hair loss was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Feeling hot, Periorbital discomfort, Swelling face
Clinical narrative: Warm flowing up left side of neck into face; Half of forehead was swollen; Half of forehead was swollen and mushy feeling.; Tightness around left eye; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 14:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to chinese food. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and vitamin D (MANUFACTURER UNKNOWN); all for unknown indication from unknown date and unknown if ongoing. On 12Mar2021 at 14:45 (also reported as within 10 minutes of shot), the patient felt something warm flowing up left side of neck into face. The patient's half of forehead was swollen and had mushy feeling. The patient had tightness around left eye. The patient stayed that way for about 4 hours. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken for the events. The clinical outcome of the events something warm flowing up left side of neck into face, half of forehead was swollen, mushy feeling and tightness around left eye were resolved on 12Mar2021 at 18:45.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Lymph node pain, Lymphadenopathy, Urticaria
Clinical narrative: Hives on wrist; Swollen / painful lymph nodes (backof neck); Swollen / painful lymph nodes (back of neck); This is a spontaneous report from a non-contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 15Apr2021 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. Medical history of the patient was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient did not receive any medications within two weeks of the COVID-19 vaccine. On 15Apr2021, after 25 mins of getting the first vaccination the patient experienced hives on wrist, swollen/painful lymph nodes; back of neck. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hives on wrist, swollen/painful lymph nodes; back of neck was recovered on an unknown date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Lymph node pain, Lymphadenopathy, Pain
Clinical narrative: 101 Fever; Chills; Aches; Swollen lymph node under right arm; Tender lymph node under right arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the right arm on 09Apr2021 at 13:45(at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, migraine, polycystic ovarian syndrome (PCOS), mitral valve prolapse and allergies (unspecified). The patient had allergy to penicillin and tree nuts. The patient previously took cefaclor (CECLOR) and cefalexin (KEFLEX) and experienced drug allergy. Concomitant medications included mometasone furoate (ASMANEX), fexofenadine hydrochloride (ALLEGRA), bisoprolol (MANUFACTURER UNKNOWN), fluoxetine (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN) all for unspecified indications from on unknown date and unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 04:00 the patient experienced fever 101 (unspecified units), chills, swollen and tender lymph node under right arm and aches. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment at home pain and fever relief. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event fever 101 (unspecified units), chills, swollen and tender lymph node under right arm and aches was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: 101 Fever; Chills; Aches; Swollen lymph node under right arm; Tender lymph node under right arm; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0162) via an unspecified route of administration in the right arm on 09Apr2021 at 13:45(at the age of 42-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma, migraine, polycystic ovarian syndrome (PCOS), mitral valve prolapse and allergies (unspecified). The patient had allergy to penicillin and tree nuts. The patient previously took cefaclor (CECLOR) and cefalexin (KEFLEX) and experienced drug allergy. Concomitant medications included mometasone furoate (ASMANEX), fexofenadine hydrochloride (ALLEGRA), bisoprolol (MANUFACTURER UNKNOWN), fluoxetine (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN) all for unspecified indications from on unknown date and unknown if ongoing. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 04:00 the patient experienced fever 101 (unspecified units), chills, swollen and tender lymph node under right arm and aches. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were taken as a result of events and included treatment at home pain and fever relief. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event fever 101 (unspecified units), chills, swollen and tender lymph node under right arm and aches was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Frequent bowel movements, Injection site pain, Nausea
Clinical narrative: Intense body aches; Muscle soreness at injection site; Fever; Chills; Nausea; Excessive Bowel movements; Tiredness; Skin Sensitivity all over body; Right ear ringing; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 17:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included oral lichen planus. The patient took unspecified compounded mouthwash but never ingested as a concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 08:00 AM, the patient experienced intense body aches, muscle soreness at injection site, fever, chills, nausea, excessive bowel movements (6 in one day), tiredness, skin sensitivity all over body and right ear ringing when the pain was really bad. Therapeutic measures were taken for the reported events included two Tylenol extra strength capsules, 500 mg each. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent lab test and procedures which included nasal swab test and the result was negative. The clinical outcome of the events intense body aches, muscle soreness at injection site, fever, chills, nausea, excessive bowel movements, tiredness, skin sensitivity all over body and right ear ringing was recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia, SARS-CoV-2 test, Sensitive skin, Tinnitus
Clinical narrative: Intense body aches; Muscle soreness at injection site; Fever; Chills; Nausea; Excessive Bowel movements; Tiredness; Skin Sensitivity all over body; Right ear ringing; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 17:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history included oral lichen planus. The patient took unspecified compounded mouthwash but never ingested as a concomitant medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 23Mar2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 08:00 AM, the patient experienced intense body aches, muscle soreness at injection site, fever, chills, nausea, excessive bowel movements (6 in one day), tiredness, skin sensitivity all over body and right ear ringing when the pain was really bad. Therapeutic measures were taken for the reported events included two Tylenol extra strength capsules, 500 mg each. Since the vaccination, the patient had been tested for COVID-19. On an unknown date, the patient underwent lab test and procedures which included nasal swab test and the result was negative. The clinical outcome of the events intense body aches, muscle soreness at injection site, fever, chills, nausea, excessive bowel movements, tiredness, skin sensitivity all over body and right ear ringing was recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Arm is very sore; sore and all joints, especially in my hands and fingers hurt; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20Apr2021 at 16:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy and sulfonamide allergy (sulfa drugs). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included elagolix sodium (ORILISSA), sertraline (MANUFACTURER UNKNOWN) and mirtazapine (MANUFACTURER UNKNOWN). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 17Mar2021 at 16:45 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 06:00, the patient experienced very sore arm and painful joints, especially in her hands and fingers hurt. On 16Apr2021, the patient underwent Nasal Swab, SARS CoV-2 test and the result was Negative. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events very sore arm and painful joints, especially in her hands and fingers hurt were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Swelling
Clinical narrative: Back pain; Lower back swollen left side and right side; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 14Apr2021 at 10:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food, or other products. Concomitant medications included ascorbic acid (VITAMIN C), colecalciferol (VITAMIN D3) and fish oil (MANUFACTURER UNKNOWN); all taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 16Apr2021 at 00:00, the patient all of a sudden started having back pain. Then the patient woke up with his lower back swollen, left side and right side. The patient was taking pain medications and was doing cold compress but pain was unbearable at times. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with unspecified pain medications. The clinical outcome of the events back pain, lower back swollen left side and right side were not recovered at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: Body ache; Chills; Tiredness; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 16:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 30Mar2021 at 15:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021, the patient experienced chills, tiredness, body ache, fever. Therapeutic measures were taken as a result of chills, tiredness, body ache, fever and included treatment with Tylenol. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care.  The clinical outcome of the events chills, tiredness, body ache, fever was not resolved at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cold sweat, Decreased appetite, Fatigue
Clinical narrative: slight nausea; After the second vaccine: body aches and pains; pain in area of injection; Neck pain; migraine; Severe Headahche; fever of 102 Fahrenheit; Vaginal bleeding; uterine cramping (I don't have menstrual periods due to birth control); sharp pain in bottom of left foot; congestion (felt like a head cold); decrease in appetite; Fatigue; Drowsiness /Slept all day; Cold sweat; Chills; Hot flashes; felt like a head cold; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 19-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0172) via an unspecified route of administration, administered in the left arm on 23Apr2021 12:00 (at the age of 19-years-old) as dose 2, single and for COVID-19 immunization. The patient's medical history included ADHD (attention deficit hyperactivity disorder), generalised anxiety disorder, PTSD (mental disorder), depression, from an unknown date and unknown if ongoing and inflammation in bowel from an unknown date and unknown if ongoing currently receiving treatment and figuring out official diagnosis. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EP7533) via an unspecified route of administration, administered in the left arm on 02Apr2021 12:00 PM (at the age of 19-years-old) as dose 1, single and for COVID-19 immunization. Concomitant medications included quetiapine fumarate (SEROQUEL), budesonide, omeprazole, medroxyprogesterone acetate (DEPO-PROVERA), taken for an unspecified indication, start and stop date were not reported. On 24Apr2021 11:00, the patient experienced slight nausea, after the second vaccine: body aches and pains, pain in area of injection, neck pain, migraine, severe headahche, fever of 102 fahrenheit, vaginal bleeding, uterine cramping (i don't have menstrual periods due to birth control), sharp pain in bottom of left foot, congestion (felt like a head cold), decrease in appetite, fatigue, drowsiness /slept all day, cold sweat, chills, hot flashes, felt like a head cold. On 24Apr2021, the patient underwent lab tests and procedures which included body temperature: 102 fahrenheit. No other vaccine in four weeks. other medications in two weeks were taken as seroquel, budesonide, omeprazole, depo-provera. No covid prior vaccination nor tested for covid post vaccination and patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies reported. No treatment reported for the adverse events. The outcome of the events was reported as recovering.  Follow-up attempts completed. No further information expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, Migraine, Nasal congestion, Nasopharyngitis
Clinical narrative: slight nausea; After the second vaccine: body aches and pains; pain in area of injection; Neck pain; migraine; Severe Headahche; fever of 102 Fahrenheit; Vaginal bleeding; uterine cramping (I don't have menstrual periods due to birth control); sharp pain in bottom of left foot; congestion (felt like a head cold); decrease in appetite; Fatigue; Drowsiness /Slept all day; Cold sweat; Chills; Hot flashes; felt like a head cold; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 19-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0172) via an unspecified route of administration, administered in the left arm on 23Apr2021 12:00 (at the age of 19-years-old) as dose 2, single and for COVID-19 immunization. The patient's medical history included ADHD (attention deficit hyperactivity disorder), generalised anxiety disorder, PTSD (mental disorder), depression, from an unknown date and unknown if ongoing and inflammation in bowel from an unknown date and unknown if ongoing currently receiving treatment and figuring out official diagnosis. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EP7533) via an unspecified route of administration, administered in the left arm on 02Apr2021 12:00 PM (at the age of 19-years-old) as dose 1, single and for COVID-19 immunization. Concomitant medications included quetiapine fumarate (SEROQUEL), budesonide, omeprazole, medroxyprogesterone acetate (DEPO-PROVERA), taken for an unspecified indication, start and stop date were not reported. On 24Apr2021 11:00, the patient experienced slight nausea, after the second vaccine: body aches and pains, pain in area of injection, neck pain, migraine, severe headahche, fever of 102 fahrenheit, vaginal bleeding, uterine cramping (i don't have menstrual periods due to birth control), sharp pain in bottom of left foot, congestion (felt like a head cold), decrease in appetite, fatigue, drowsiness /slept all day, cold sweat, chills, hot flashes, felt like a head cold. On 24Apr2021, the patient underwent lab tests and procedures which included body temperature: 102 fahrenheit. No other vaccine in four weeks. other medications in two weeks were taken as seroquel, budesonide, omeprazole, depo-provera. No covid prior vaccination nor tested for covid post vaccination and patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies reported. No treatment reported for the adverse events. The outcome of the events was reported as recovering.  Follow-up attempts completed. No further information expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Neck pain, Pain, Pain in extremity, Pyrexia
Clinical narrative: slight nausea; After the second vaccine: body aches and pains; pain in area of injection; Neck pain; migraine; Severe Headahche; fever of 102 Fahrenheit; Vaginal bleeding; uterine cramping (I don't have menstrual periods due to birth control); sharp pain in bottom of left foot; congestion (felt like a head cold); decrease in appetite; Fatigue; Drowsiness /Slept all day; Cold sweat; Chills; Hot flashes; felt like a head cold; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 19-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0172) via an unspecified route of administration, administered in the left arm on 23Apr2021 12:00 (at the age of 19-years-old) as dose 2, single and for COVID-19 immunization. The patient's medical history included ADHD (attention deficit hyperactivity disorder), generalised anxiety disorder, PTSD (mental disorder), depression, from an unknown date and unknown if ongoing and inflammation in bowel from an unknown date and unknown if ongoing currently receiving treatment and figuring out official diagnosis. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EP7533) via an unspecified route of administration, administered in the left arm on 02Apr2021 12:00 PM (at the age of 19-years-old) as dose 1, single and for COVID-19 immunization. Concomitant medications included quetiapine fumarate (SEROQUEL), budesonide, omeprazole, medroxyprogesterone acetate (DEPO-PROVERA), taken for an unspecified indication, start and stop date were not reported. On 24Apr2021 11:00, the patient experienced slight nausea, after the second vaccine: body aches and pains, pain in area of injection, neck pain, migraine, severe headahche, fever of 102 fahrenheit, vaginal bleeding, uterine cramping (i don't have menstrual periods due to birth control), sharp pain in bottom of left foot, congestion (felt like a head cold), decrease in appetite, fatigue, drowsiness /slept all day, cold sweat, chills, hot flashes, felt like a head cold. On 24Apr2021, the patient underwent lab tests and procedures which included body temperature: 102 fahrenheit. No other vaccine in four weeks. other medications in two weeks were taken as seroquel, budesonide, omeprazole, depo-provera. No covid prior vaccination nor tested for covid post vaccination and patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies reported. No treatment reported for the adverse events. The outcome of the events was reported as recovering.  Follow-up attempts completed. No further information expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Somnolence, Uterine spasm, Vaccination site pain, Vaginal haemorrhage
Clinical narrative: slight nausea; After the second vaccine: body aches and pains; pain in area of injection; Neck pain; migraine; Severe Headahche; fever of 102 Fahrenheit; Vaginal bleeding; uterine cramping (I don't have menstrual periods due to birth control); sharp pain in bottom of left foot; congestion (felt like a head cold); decrease in appetite; Fatigue; Drowsiness /Slept all day; Cold sweat; Chills; Hot flashes; felt like a head cold; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 19-year-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EW0172) via an unspecified route of administration, administered in the left arm on 23Apr2021 12:00 (at the age of 19-years-old) as dose 2, single and for COVID-19 immunization. The patient's medical history included ADHD (attention deficit hyperactivity disorder), generalised anxiety disorder, PTSD (mental disorder), depression, from an unknown date and unknown if ongoing and inflammation in bowel from an unknown date and unknown if ongoing currently receiving treatment and figuring out official diagnosis. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EP7533) via an unspecified route of administration, administered in the left arm on 02Apr2021 12:00 PM (at the age of 19-years-old) as dose 1, single and for COVID-19 immunization. Concomitant medications included quetiapine fumarate (SEROQUEL), budesonide, omeprazole, medroxyprogesterone acetate (DEPO-PROVERA), taken for an unspecified indication, start and stop date were not reported. On 24Apr2021 11:00, the patient experienced slight nausea, after the second vaccine: body aches and pains, pain in area of injection, neck pain, migraine, severe headahche, fever of 102 fahrenheit, vaginal bleeding, uterine cramping (i don't have menstrual periods due to birth control), sharp pain in bottom of left foot, congestion (felt like a head cold), decrease in appetite, fatigue, drowsiness /slept all day, cold sweat, chills, hot flashes, felt like a head cold. On 24Apr2021, the patient underwent lab tests and procedures which included body temperature: 102 fahrenheit. No other vaccine in four weeks. other medications in two weeks were taken as seroquel, budesonide, omeprazole, depo-provera. No covid prior vaccination nor tested for covid post vaccination and patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No known allergies reported. No treatment reported for the adverse events. The outcome of the events was reported as recovering.  Follow-up attempts completed. No further information expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Confusional state, Dysgeusia, Hypoaesthesia
Clinical narrative: Metallic taste in mouth; Left arm turned numb; Hives and rash; Whole body stayed numb for several minutes with mental confusion; not being able to speak properly; Blood pressure increased; This is a spontaneous report from a contactable other health care professional. A 26-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: ER8733), dose 1 via an unspecified route of administration, administered in left arm on 26Apr2021 at 15:15 (at the age of 26-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history reported as none. Concomitant medication was not reported. The patient was not pregnant at the time of vaccination. Patient did not have allergies. No other vaccine in four weeks. No other medications in two weeks. No COVID prior vaccination. Facility type vaccine at hospital. On 26Apr2021 at 15:15, the patient experienced metallic taste in mouth 1-2 minutes from injection. 5-7 min after injection left arm turned numb, spread to left arm and rest of body. Hives and rash started developing on neck and face. Whole body stayed numb for several minutes with mental confusion and not being able to speak properly. Blood pressure increase. The patient underwent lab tests and procedures which included blood pressure measurement: increased. Adverse event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treated in Emergency Room for allergic reaction. Adverse event treatment: Pretison, steroid, Benadryl and Pepcid. No COVID tested post vaccination. The outcome of the events were not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Speech disorder, Urticaria
Clinical narrative: Metallic taste in mouth; Left arm turned numb; Hives and rash; Whole body stayed numb for several minutes with mental confusion; not being able to speak properly; Blood pressure increased; This is a spontaneous report from a contactable other health care professional. A 26-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Batch/Lot Number: ER8733), dose 1 via an unspecified route of administration, administered in left arm on 26Apr2021 at 15:15 (at the age of 26-years-old) as DOSE 1, SINGLE for COVID-19 immunization. Medical history reported as none. Concomitant medication was not reported. The patient was not pregnant at the time of vaccination. Patient did not have allergies. No other vaccine in four weeks. No other medications in two weeks. No COVID prior vaccination. Facility type vaccine at hospital. On 26Apr2021 at 15:15, the patient experienced metallic taste in mouth 1-2 minutes from injection. 5-7 min after injection left arm turned numb, spread to left arm and rest of body. Hives and rash started developing on neck and face. Whole body stayed numb for several minutes with mental confusion and not being able to speak properly. Blood pressure increase. The patient underwent lab tests and procedures which included blood pressure measurement: increased. Adverse event resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treated in Emergency Room for allergic reaction. Adverse event treatment: Pretison, steroid, Benadryl and Pepcid. No COVID tested post vaccination. The outcome of the events were not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia
Clinical narrative: Woke up approximately 10 hours after injection with the chills; spent the following day with a fever that fluctuated between 99.4F and 99.7F; Overall body fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the left arm on 20Apr2021 at 13:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. The patient had no allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (CETIRIZINE HCL) for unspecified indication from unknown date and unknown if ongoing. The patient did not receive any vaccination within four weeks prior to the COVID-19 vaccine. The patient  previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number; ER8732) via an unspecified route of administration in the left arm on 29Mar2021 at 10:30 (at the age of 39-years-old), as a single dose for COVID-19 immunisation. On 21Apr2021 at 00:00, approximately 10 hours after injection, the patient woke up with the chills, spent the following day with a fever that fluctuated between 99.4F and 99.7F and overall body fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of chills, spent the following day with a fever that fluctuated between 99.4F and 99.7F and overall body fatigue and included treatment with NSAIDs which was effective and comprised of 600-mg ibuprofen followed by 1000mg tylenol started 8 hours later (at unspecified time of the day). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events woke up approximately 10 hours after injection with the chills, spent the following day with a fever that fluctuated between 99.4F and 99.7F and overall body fatigue was recovered on an unknown date in Apr2021.  No follow-up attempts are possible. No further information is expected.